Suppr超能文献

肾功能中度降低的南亚和欧洲白人糖尿病成年人在肾病进展方面是否存在差异?

Is there a difference in progression of renal disease between South Asian and white European diabetic adults with moderately reduced kidney function?

作者信息

Pallayova Maria, Rayner Hugh, Taheri Shahrad, Dasgupta Indranil

机构信息

Renal Unit, Heartlands Hospital, Bordesley Green East, Birmingham, UK; Department of Human Physiology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Slovak Republic.

Renal Unit, Heartlands Hospital, Bordesley Green East, Birmingham, UK.

出版信息

J Diabetes Complications. 2015 Aug;29(6):761-5. doi: 10.1016/j.jdiacomp.2015.05.012. Epub 2015 May 29.

Abstract

AIMS

We examined potential ethnicity-related differences in progression of chronic kidney disease (CKD) between South Asian and white European diabetic adults with CKD stage 3 over a 5-year period.

METHODS

We analysed data collected from diabetic adults of white European and South Asian ethnicity who had attended diabetes and diabetes-renal outpatient clinics with baseline estimated glomerular filtration rate (eGFR) values ≥30 and <60 ml/min/1.73 m(2) over 5 years (2005-2010); 891 (76%) were white Europeans, 282 (24%) were South Asians.

RESULTS

Despite similar baseline eGFR (P=0.103), South Asians were younger [median (interquartile range) 68 (63-73) vs. 70 (64-77) years; P<0.001] and had worse baseline glycated haemoglobin than white Europeans [8.0 (7.0-9.1) vs. 7.6 (6.8-8.7)%; P=0.004]. The 5-year follow-up eGFR and the decline in eGFR did not differ between the two groups. Thirty-five (12.4%) South Asians and 82 (9.2%) white Europeans progressed to stages 4-5 CKD (P=0.112). There was a trend towards higher follow-up glycated haemoglobin levels in South Asians (P=0.064).

CONCLUSIONS

Despite worse glycaemic control, South Asian diabetic adults with CKD stage 3 did not show any difference in 5-year decline in eGFR compared with white Europeans. These data do not support ethnic differences in progression of CKD between the South Asian and white European patient populations.

摘要

目的

我们研究了南亚裔和欧洲裔白人糖尿病成年慢性肾脏病(CKD)3期患者在5年期间CKD进展方面潜在的种族差异。

方法

我们分析了从欧洲裔白人和南亚裔糖尿病成年患者收集的数据,这些患者在5年期间(2005 - 2010年)因糖尿病和糖尿病肾病就诊于门诊,基线估计肾小球滤过率(eGFR)值≥30且<60 ml/min/1.73 m²;891例(76%)为欧洲裔白人,282例(24%)为南亚裔。

结果

尽管基线eGFR相似(P = 0.103),但南亚裔患者更年轻[中位数(四分位间距)68(63 - 73)岁对70(64 - 77)岁;P < 0.001],且基线糖化血红蛋白水平比欧洲裔白人更差[8.0(7.0 - 9.1)%对7.6(6.8 - 8.7)%;P = 0.004]。两组间5年随访eGFR及eGFR下降情况无差异。35例(12.4%)南亚裔和82例(9.2%)欧洲裔白人进展至CKD 4 - 5期(P = 0.112)。南亚裔患者随访糖化血红蛋白水平有升高趋势(P = 0.064)。

结论

尽管血糖控制较差,但CKD 3期的南亚裔糖尿病成年患者与欧洲裔白人相比,5年eGFR下降无差异。这些数据不支持南亚裔和欧洲裔白人患者群体在CKD进展方面存在种族差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验